Negative trial results are important to understand the mechanisms of multimodality therapy in gastric cancer Christoph Schuhmacher Editorial 01 July 2011 Pages: 203 - 205
Second-line chemotherapy for gastric cancer: a new issue lies ahead in global trials Hiroya Takiuchi Review article 23 July 2011 Pages: 206 - 211
Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2 Isao MiyashiroHiroshi FurukawaThe Gastric Cancer Surgical Study Group in the Japan Clinical Oncology Group Original Article 19 February 2011 Pages: 212 - 218
Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum Katrine R. SchoennemannJon K. BjerregaardPer Pfeiffer Original Article 17 March 2011 Pages: 219 - 225
A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial) Tetsuya HamaguchiKuniaki ShiraoGastrointestinal Oncology Study Group of Japan Clinical Oncology Group Original Article 19 April 2011 Pages: 226 - 233
Prognostic relevance of demographics and surgical practice for patients with gastric cancer in two centers: in Poland versus Germany Radoslaw JaworskiElfriede BollschweilerJanusz Jaskiewicz Original Article Open access 26 March 2011 Pages: 234 - 241
p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population Hye-Rim SongSun-Seog KweonMin-Ho Shin Original Article 02 April 2011 Pages: 242 - 247
Erratum to: p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population Hye-Rim SongSun-Seog KweonMin-Ho Shin Erratum 22 July 2011 Pages: 248 - 248
Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer Hyun Jeong ShimJu Young YunIk Joo Chung Original Article 23 March 2011 Pages: 249 - 256
Increased risk of tuberculosis after gastrectomy and chemotherapy in gastric cancer: a 7-year cohort study Shiang-Fen HuangChung-Pin LiWei-Juin Su Original Article 19 April 2011 Pages: 257 - 265
IL-6 serum levels predict postoperative morbidity in gastric cancer patients Antoni M. SzczepanikLucyna ScisloJan Kulig Original Article Open access 20 April 2011 Pages: 266 - 273
Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1 Toru AoyamaTakaki YoshikawaAkira Tsuburaya Original Article 02 April 2011 Pages: 274 - 278
Functional outcomes according to the size of the gastric remnant and type of reconstruction following laparoscopic distal gastrectomy for gastric cancer Eiji NomuraSang-Woong LeeNobuhiko Tanigawa Original Article 26 April 2011 Pages: 279 - 284
Does immigration play a role in the risk of gastric cancer by site and by histological type? A study of first-generation immigrants in Sweden Seyed Mohsen MousaviJan SundquistKari Hemminki Short Communication 23 March 2011 Pages: 285 - 289
Gastric adenocarcinoma with rhabdoid morphology Kohei ShomoriKenji SugamuraHisao Ito Case Report 17 March 2011 Pages: 290 - 294
Early gastric cancer combined with multiple metachronous osteosclerotic bone and bone marrow metastases that responded to chemoradiotherapy Masaaki SaitoHirokazu KiyozakiFumio Konishi Case report 14 June 2011 Pages: 295 - 299
